Literature DB >> 20929296

Grey matter volume changes over the whole brain in amyotrophic lateral sclerosis: A voxel-wise meta-analysis of voxel based morphometry studies.

Zhiye Chen1, Lin Ma.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with selected both upper and lower motor neuron involvement. Although some inconsistent results exist, both pathological studies and many structural neuroimaging studies have revealed brain volume changes in ALS. To provide an objective overview of structural changes in ALS, a voxel-wise meta-analysis was performed in published voxel based morphometry (VBM) studies. A systematic search of VBM studies was applied in ALS. Five studies met the inclusion criteria, comprising 84 ALS patients and 81 normal controls. A voxel-wise meta-analysis was performed on the retrieved VBM studies using signed differential mapping. Descriptive analysis showed that 25% of ALS patients had right precentral gyrus atrophy (2373 voxels). Group analysis demonstrated regional grey matter loss over the whole brain in the right precentral gyrus (p = 7.96 × 10(-4)). Sensitivity analysis showed good sensitivity (157 voxels). In conclusion, right precentral grey matter atrophy was a common finding and prominent feature of brain structural changes in ALS.

Entities:  

Mesh:

Year:  2010        PMID: 20929296     DOI: 10.3109/17482968.2010.516265

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  29 in total

1.  A meta-analysis of voxel-based morphometric studies on migraine.

Authors:  Wenting Hu; Jian Guo; Ning Chen; Jiang Guo; Li He
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Frequency-specific alterations in the fractional amplitude of low-frequency fluctuations in amyotrophic lateral sclerosis.

Authors:  Xujing Ma; Jiuquan Zhang; Youxue Zhang; Heng Chen; Rong Li; Zhiliang Long; Junjie Zheng; Jian Wang; Huafu Chen
Journal:  Neurol Sci       Date:  2016-05-02       Impact factor: 3.307

3.  Amide signal intensities may be reduced in the motor cortex and the corticospinal tract of ALS patients.

Authors:  Zhuozhi Dai; Sanjay Kalra; Dennell Mah; Peter Seres; Hongfu Sun; Renhua Wu; Alan H Wilman
Journal:  Eur Radiol       Date:  2020-09-09       Impact factor: 5.315

Review 4.  Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis.

Authors:  Esther Verstraete; Bradley R Foerster
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

Review 5.  ALS biomarkers for therapy development: State of the field and future directions.

Authors:  Michael Benatar; Kevin Boylan; Andreas Jeromin; Seward B Rutkove; James Berry; Nazem Atassi; Lucie Bruijn
Journal:  Muscle Nerve       Date:  2015-12-29       Impact factor: 3.217

Review 6.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

Review 7.  Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.

Authors:  Robert Bowser; Martin R Turner; Jeremy Shefner
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

Review 8.  Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Colin J Mahoney; Rebekah M Ahmed; William Huynh; Sicong Tu; Jonathan D Rohrer; Richard S Bedlack; Orla Hardiman; Matthew C Kiernan
Journal:  CNS Drugs       Date:  2021-05-15       Impact factor: 5.749

Review 9.  Mechanisms, models and biomarkers in amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Robert Bowser; Lucie Bruijn; Luc Dupuis; Albert Ludolph; Michael McGrath; Giovanni Manfredi; Nicholas Maragakis; Robert G Miller; Seth L Pullman; Seward B Rutkove; Pamela J Shaw; Jeremy Shefner; Kenneth H Fischbeck
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-05       Impact factor: 4.092

10.  Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum.

Authors:  Patricia Lillo; Eneida Mioshi; James R Burrell; Matthew C Kiernan; John R Hodges; Michael Hornberger
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.